Announcements Trials
Browse Landscape

Phase

Phase NA 439Phase 2 28Phase 3 20Phase EARLY_PHASE1 7Phase 2/3 6Phase 1 6Phase 4 4Phase 1/2 4

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other 3Other hematologic neoplasm 1Lymphoid 1Endocrine 1

Conditions

Obesity 3Polycystic Ovary Syndrome 2Sexual Dysfunction, Physiological 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Non-alcoholic Fatty Liver Disease 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Inflammation 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Exercise × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT05702905 2024-03-25

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Peking University First Hospital

Phase 4 Unknown
75 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT01554735 2015-07-29

Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men

Changi General Hospital

Phase 4 Completed
70 enrolled
EndocrineOther

Inflammation, Obesity, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

NCT00593294 2008-01-15

Oral Contraceptive and Cardiovascular Risk in PCOS

Federico II University

Phase 4 Completed
150 enrolled

Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡